Equities

Pharmaniaga Bhd

PHARMA:KLS

Pharmaniaga Bhd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (MYR)0.305
  • Today's Change0.00 / 0.00%
  • Shares traded1.79m
  • 1 Year change-18.67%
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Pharmaniaga Berhad is an investment holding company. The Company is principally engaged in the research and development, manufacturing of generic drugs and medical devices, logistics and distribution, sales, and marketing, as well as community pharmacy. The Company operates through three segments: Logistics and distribution, Manufacturing, and Indonesia. The Logistics and distribution is engaged in the distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia. The Manufacturing segment is engaged in the manufacturing of pharmaceutical products in Malaysia. Indonesia segment is engaged in the manufacturing and distribution of pharmaceutical and medical products in Indonesia. The Company’s subsidiaries include Idaman Pharma Manufacturing Sdn. Bhd., Pharmaniaga Manufacturing Berhad, Pharmaniaga LifeScience Sdn. Bhd., Pharmaniaga Logistics Sdn. Bhd., and Pharmaniaga Marketing Sdn. Bhd.

  • Revenue in MYR (TTM)3.40bn
  • Net income in MYR-77.45m
  • Incorporated1998
  • Employees3.78k
  • Location
    Pharmaniaga Bhd7 Lorong Keluli 1BKawasan Perindustrian BukitRaja Selatan, Seksyen 7SHAH ALAM 40000MalaysiaMYS
  • Phone+60 333429999
  • Fax+60 333417777
  • Websitehttps://pharmaniaga.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Kim Forest Enterprise Co Ltd60.64m-19.49m287.51m----3.48--4.74-2.85-2.858.8911.290.49863.344.31---16.02-0.8245-19.78-1.0613.1531.99-32.14-1.251.19-82.430.2664---38.1112.36-341.58---8.51--
Sinco Pharmaceuticals Holdings Ltd1.65bn27.50m289.46m278.0010.530.70987.620.17550.02250.02251.350.33391.5322.605.739,875,025.002.566.486.5520.2212.7314.791.673.861.0828.200.28597.2111.8221.66-39.03--123.63--
Hyphens Pharma International Ltd594.26m29.85m317.74m440.0010.651.458.020.53470.02770.02770.55130.20371.454.654.89387,715.907.298.3512.1014.0136.2937.065.035.651.35--0.093933.005.107.12-24.529.63-18.709.35
Harima-Kyowa Co., LTD.1.85bn42.36m346.24m197.008.070.47067.890.1867261.75261.7511,459.404,490.241.9123.795.51--4.364.395.705.8711.5711.732.282.232.22--0.013117.152.375.011.103.2534.303.44
Able View Global Inc698.44m44.26m354.76m98.008.116.717.830.50790.22290.22293.520.26952.726.208.371,520,406.0017.80--30.88--24.84--6.54--1.997.900.2017--2.58--23.46------
Natural Health Trends Corp.201.63m2.34m379.51m138.00161.872.06124.181.880.04340.04343.753.420.5822.24--311,695.700.6751-0.53980.9333-0.709974.3074.061.16-0.95712.77--0.00---10.60-25.5481.47-54.86-26.476.64
Balaxi Pharmaceuticals Ltd147.50m-2.94m402.96m51.00------2.73-5.30-5.30255.76--------51,400,510.00--31.86--46.0742.4532.28-1.9915.43--------20.42---3.56--314.83--
Pharmaniaga Berhad3.40bn-77.45m439.58m3.78k------0.1291-0.0572-0.05722.55-0.20561.824.599.57---4.06-6.88---38.459.046.64-2.23-3.660.27621.371.29---3.027.3887.25--23.35--
Sopharma Trading AD4.38bn76.09m526.80m2.62k6.921.643.300.12030.85210.852149.053.592.770.15657.98642,620.804.802.3914.547.8898.0498.091.741.010.5952187.590.615--13.0213.26221.6727.863.70--
111 Inc - ADR9.70bn-254.83m534.06m1.66k------0.0551-0.6425-0.642524.55-0.96174.569.6629.15---10.77-17.09---178.255.685.36-2.36-4.370.5457-32.730.5781--10.5952.955.80------
EQL Pharma AB115.58m9.93m550.60m21.0056.667.08--4.760.76420.76428.886.120.80121.744.8012,579,430.006.899.0211.9015.2743.5537.958.598.290.56948.880.4032--1.6439.64-26.57--32.73--
Data as of May 17 2024. Currency figures normalised to Pharmaniaga Bhd's reporting currency: Malaysian Ringgit MYR

Institutional shareholders

7.87%Per cent of shares held by top holders
HolderShares% Held
Lembaga Tabung Angkatan Tenteraas of 31 Mar 2023112.88m7.83%
MIDF Amanah Asset Management Bhd.as of 15 Jul 2020600.00k0.04%
LGT Capital Partners AG (Investment Management)as of 31 May 20230.000.00%
RHB Asset Management Sdn. Bhd.as of 30 Jun 20230.000.00%
Grantham, Mayo, Van Otterloo & Co. LLCas of 30 Sep 20210.000.00%
More ▼
Data from 15 Mar 2023 - 16 Feb 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.